Clinical Trials
🇺🇸 FDA Page 26FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 301–312 of 380 articles
Mabwell's 9MW2821 Becomes First Nectin-4 ADC to Enter Phase III Trial for Triple-Negative Breast Cancer
Vistagen Receives FDA Approval to Advance Refisolone Phase 2 Trial for Menopause Hot Flashes
Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion
Oncology Data Landscape 2026: Key Trends & Upcoming Readouts
ReDI 2026: FDA Regulatory Strategies Conference Recap
OCT East Coast 2026: CRO Trends & Outsourcing Strategies
Alterity Therapeutics ATH434 Shows Reduced Functional Decline in Multiple System Atrophy Phase 2 Trial
Tempest Therapeutics Achieves Manufacturing Milestone for TPST-2003 CAR-T Cancer Treatment
Phanes Therapeutics to Present Updated Spevatamig Phase 2 Results for Metastatic Pancreatic Cancer at ASCO 2026
NETRIS Pharma's NP137 Shows Promising Results in Pancreatic Cancer Phase 1b Trial Published in Nature
Neurosterix NTX-253 Phase 1 Schizophrenia Trial On Track for Q2 2026 Completion
Mabwell 9MW2821 Combination Therapy Data to Be Presented at ASCO 2026 for Urothelial Carcinoma Treatment